aTyr Pharma Announces One-for-40 Reverse Stock Split
aTyr Pharma will effect a 1-for-40 reverse stock split effective 5:00 p.m. ET on October 28, 2026, with split-adjusted trading starting October 29 under the existing symbol ATYR. The split was approved by stockholders on October 16 and is intended to bring the company into compliance with Nasdaq's minimum bid price requirement for continued listing on the Capital Market. Outstanding shares fall from roughly 100.5 million to about 2.5 million, with a new CUSIP (002120301); authorized shares remain 340 million and fractional shares are rounded up.
Key figures
- Effective date
- 2026-10-28
- Authorized shares
- 340000000
- Reverse split ratio
- 1-for-40
- Shares outstanding after
- 2500000
- Shares outstanding before
- 100500000
- Split adjusted trading start
- 2026-10-29
AI analysis
Red flags3 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.